Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/401129]Researchers: Prof Glenn Marshall (Principal investigator) , Prof Michelle Haber , Prof Murray Norris
Brief description One in three children with cancer still die of their disease, and side-effects of treatment are considerable. Over the past 15 years, the Chief Investigators have established themselves as a leading international research group in child cancer and have successfully applied their laboratory-based discoveries to improve the clinical management of children with malignant diseases. In particular, key advances have been made in basic cell biology, molecular biology and in defining clinically relevant molecular targets and prognostic indicators for the child cancer, neuroblastoma, the commonest solid tumour in young children. These findings have been made possible by the team assembling, over recent years, an extensive and unique range of in vitro and in vivo model systems, together with a large bank of clinical neuroblastoma specimens. In this research program, the team members propose an experimental approach that will continue their studies, focussing on cancer initiation and better target identification within cancer cells, leading to the development of effective and non-toxic novel compounds, possibly prevention strategies,and introduction of novel therapies into clinical trial.
Funding Amount $AUD 5,029,092.14
Funding Scheme Programs
Notes Program Grant
- nhmrc : 401129
- PURL : https://purl.org/au-research/grants/nhmrc/401129